Monday, September 14, 2026

Belvarafenib: The Promising New Targeted Cancer Drug for NRAS Mutant Melanoma

Hanmi Pharmaceutical presents Belvarafenib's phase 2 trial for NRAS mutant melanoma at KCA 2026, targeting unmet medical needs.

How Nota’s AI Model Optimization Will Revolutionize LG’s Humanoid Robots in 2026

AI model optimization firm Nota will optimize the Vision Language Action Model for LG Electronics' humanoid robots.

How ARKO’s 2025 Sustainability Report Achieved Platinum Award: A Deep Dive into ESG Excellence

ARKO wins top ESG management awards for its sustainability reports, showcasing commitment to sustainable values in the arts sector.

Tag: Cannes

North KoreaKoreaKimMilitaryAISouth Koreamarketrelationsdevelopment

No posts to display

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.